Real‐World Outcomes After Dupilumab Initiation for Pediatric Chronic Rhinosinusitis with Nasal Polyps
OBJECTIVE: To evaluate whether dupilumab initiation is associated with reduced short-term flare burden, healthcare utilization, and surgical escalation in pediatric patients with chronic rhinosinusitis with nasal polyps (CRSwNP). STUDY DESIGN: Retrospective cohort study. SETTING: TriNetX United States Collaborative Network. METHODS: Patients aged ≤18 years with chronic rhinosinusitis with nasal polyps were identified between January 1, 2015, and December 31, 2024. Dupilumab-treated patients were indexed at treatment initiation and propensity score-matched 1:1 to nondupilumab controls indexed at a systemic corticosteroid burst based on asthma, atopic dermatitis, allergic rhinitis, and prior endoscopic sinus surgery. Outcomes within 12 months were compared using risk ratios. RESULTS: In 442 matched patients (221 per cohort), dupilumab-treated patients had lower rates of acute sinusitis (12/221 [5.4%] vs 31/221 [14.0%]; risk ratio [RR] 0.39; 95% CI: 0.20-0.73; P = .002), systemic corticosteroid bursts (80/221 [36.2%] vs 101/221 [45.7%]; RR 0.79; 95% CI: 0.63-0.99; P = .042), and functional endoscopic sinus surgery (19/221 [8.6%] vs 38/221 [17.2%]; RR 0.50; 95% CI: 0.30-0.84; P = .007). Nasal polyp diagnoses were more frequently documented in the dupilumab-treated cohort (148/221 [67.0%] vs 95/221 [43.0%]; P < .0001), while emergency department visits (16/221 [7.2%] vs 27/221 [12.2%]; P = .078) and inpatient admissions (12/221 [5.4%] vs 16/221 [7.2%]; P = .435) were similar between cohorts. CONCLUSION: These findings suggest that dupilumab may be a steroid-sparing and surgery-sparing option in pediatric CRSwNP.
Authors
- Michele M. Carr (ORCID: https://orcid.org/0000-0002-7406-4467)
- Deepthi S. Akella (ORCID: https://orcid.org/0000-0001-5395-7402)
- Paula Valeria Guerra-Navarro (ORCID: https://orcid.org/0009-0000-0366-7239)
- Maaz S. Haji (ORCID: https://orcid.org/0009-0006-1216-2578)
- Abraham A Kassem (ORCID: https://orcid.org/0009-0004-9674-7332)
- Alexa Ibrahim (ORCID: https://orcid.org/0009-0006-0879-9787)
Institutions
- Rosalind Franklin University of Medicine and Science (US)
- Jacobs Institute (US)
- University at Buffalo, State University of New York (US)
- University of Missouri (US)
Publication Details
- Journal
- Otolaryngology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1002/ohn.70523
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00